Table 1 Patients characteristic with regard to the inclusion groups
Characteristics | Placebo (n = 59) | NAC (n = 55) |
|---|---|---|
Age (years) | 78.2 ±11.8 | 78.1 ± 12.0 |
Sex (M/F) | 29/30 | 28/27 |
BMI (kg/m2) | 24.4 ± 4.6 | 25.0 ± 4.8 |
Diabetes | 11 (19%) | 15 (27%) |
Blood pressure (mmHg) | ||
Diastolic | 69.1 ± 11.7 | 67.0 ± 17.2 |
Systolic | 129.5 ± 20.8 | 132.9 ± 22.5 |
Contrast medium (mL) | 117.7 ± 3.2 | 117.4 ± 1.8 |
Creatinine (μmol/L) | 133.5 ± 34.8 | 132.4 ± 34.8 |
Cystatin C (mg/L) | 1.9 ± 0.5 | 1.9 ± 0.6 |
eGFR (MDRD) (ml/min/1.73) | 41.7 ± 1.2 | 42.7 ± 1.2 |
Antibiotics | 16 (27%) | 16 (29%) |
Angiotensin-converting enzyme inhibitor (ACE-1 inhibitor) | 28 (48%) | 25 (45%) |
Non-steroidal antiinflammatory drugs (NSAIDS) | 1 (2%) | 5 (9%) |
Diuretics | 27 (46%) | 25 (45%) |